Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on Mar 26, 2012 8:44pm
203 Views
Post# 19720636

RE: RE: Surprise surprise - numbers are out

RE: RE: Surprise surprise - numbers are out

Well Pleazu,

 

Maybe it's because I've been a shareholder for +12 years in that company is the reason why I  won't get excited with this.

 

This is a record year simply because we have a non recurrent one shot deal, which was a write off of debt.

 

It's not a deal with $ 800K of upfront or $ 2M of upfront that will get me excited.

 

I will get excited when there will be no spectra of financing because we still have a weak cashflow position, and I will get excited when I will see higher recurring revenues and the therapeutic deals deliver.

 

And don't get me wrong, I'm seeing a very bright future here, and a better 2012 year. I'm ready to bet that the resins sales in 2012 will beat the total revenues of 2011 including the licence fee.

 

But as far as I'm concern, Q4 was not what was expected in term of resins sales.  $ 2.4M of resins sales is beyond expectations.

 

That's all! 

Bullboard Posts